Table 3.
The results of sensitivity analyses.
| PCMa | Excluding participants with hypercholesteremiab | |||
|---|---|---|---|---|
| OR (95% Cl) | p | OR (95% Cl) | p | |
| Continuous models | ||||
| NHHR | 1.20(1.03,1.39) | 0.0176 | 2.16(1.83,2.54) | < 0.0001 |
| Categorical model | ||||
| Quartile 1 | Reference | Reference | ||
| Quartile 2 | 1.25(0.93,1.66) | 0.1211 | 1.30(0.76,2.24) | 0.1659 |
| Quartile 3 | 1.67(1.21,2.30) | 0.0030 | 1.90(1.01,3.60) | 0.0492 |
| Quartile 4 | 2.20(1.74,2.79) | < 0.0001 | 3.17(1.45,6.93) | 0.0238 |
OR odds ratio; CI confidence interval.
aPCM was performed based on age, sex, race, marital status, family PIR, education level, BMI, ALT, AST, hypertension, diabetes, and smoking status.
bAdjustments were made for age, sex, race, marital status, family PIR, education level, BMI, ALT, AST, hypertension, diabetes, and smoking status.